ArticleJournal of oral biology and craniofacial research
Assessment of
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Periodontitis is a chronic inflammatory disease resulting from microbial biofilm and host immune responses, leading to progressive loss of periodontal attachment. Although scaling and root planing (SRP) remains the primary nonsurgical treatment, adjunctive therapies may enhance clinical and biochemical outcomes. This study evaluated the efficacy of a thermoreversible Material and methods: Thirty patients (90 sites) with Stage III periodontitis were randomly assigned to three groups: Group I - SRP alone, Group II - SRP + tetracycline fibers, and Group III - SRP + 5% MO gel. Clinical parameters and gingival crevicular fluid biomarkers (periostin, nitric oxide [NO], and total antioxidant capacity [TAOC]) were assessed at baseline and two months post-treatment. Data were analyzed using ANOVA followed by post-hoc comparisons. Results: All groups showed significant clinical improvement (p < 0.001). Adjunctive groups demonstrated greater reductions in plaque, gingival, and bleeding indices than SRP alone. The MO group showed a significantly higher increase in periostin levels compared with the tetracycline group (p = 0.029) and the largest reduction in NO concentrations (p < 0.001). TAOC increased across all groups, with numerically higher yet nonsignificant values in the MO group. Conclusion: The
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.